Andreatta K. et al.: Long-term Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide After Switch From Boosted Protease Inhibitor-Based Regimens Including in Those With Preexisting Resistance and Viral Blips

Zurück zur Übersicht

27.-30.10.2021 / EACS